n | SJ | TJ | enthes. | Ptpain | EGA | PGA | HAQ | dactylitis | ESR | CRP | |
---|---|---|---|---|---|---|---|---|---|---|---|
PD-j-score | |||||||||||
0 | 14 | 0 (0–4) | NS | – | NS | NS | NS | NS | – | 6.5 (1–17) | NS |
≥1 | 56 | 1 (0–15)** | 10 (1–74)* | ||||||||
PD-perisyn | |||||||||||
0 | 60 | NS | NS | – | NS | NS | NS | NS | – | NS | NS |
≥1 | 10 | ||||||||||
PD-MASEI+E | |||||||||||
0 | 27 | – | – | NS | NS | NS | NS | NS | – | NS | NS |
≥1 | 43 | ||||||||||
PD-teno | |||||||||||
0 | 47 | 0 (0–10) | 2 (0–59) | – | NS | NS | 30 (0–80) | NS | NS | 6 (1–47) | 2 (0–20.3) |
≥1 | 23 | 3 (0–15.)** | 7 (0–33)** | 40 (0–80)* | 18 (5–74)*** | 4.8 (0.6–49.5)* | |||||
PD-dactylitis | |||||||||||
0 | 65 | 1 (0–15) | 3 (0–59 | – | NS | 20 (0–80) | NS | NS | 0 (0–10) | NS | NS |
≥1 | 5 | 5 (3–13)** | 13 (6–26)* | 30 (30–60)* | 2 (0–4)*** |
Data are shown as median and range in parenthesis.
Ptpain, EGA and PGA were measured on a Visual Analogue Ccale (range 0–100 mm) and are expressed in millimetres.
*p<0.05.
**p<0.01.
***p<0.001.
–, not tested; CRP, C reactive protein (normal range 0–5 mg/L); EGA, evaluator's global assessment of disease activity; enthes., number of painful entheses according to Leeds, clinical MASEI or clinical MAEI+E scores; ESR, erythrocyte sedimentation rate (normal range 0–10 mm/first hour); HAQ, Health Assessment Questionnaire; dactylitis, dactylitis score; MASEI, Madrid Sonographic Enthesis Index; n, number of cases; NS, not significant; PD-dactylitis, ultrasound-defined dactylitis with PD-signals at involved joints and/or tendons; PD-j-score, power Doppler (PD)-score of joints; PD-MASEI-E, sum of entheses with PD-signals; enthesal sites were scanned according to Madrid Sonographic Enthesis Index plus lateral epicondyle; PD-perisyn, PD within peritendinous tissue; PD-teno, sum score of PD-signals related to tenosynovitis; PGA, patient's global assessment of disease activity; Ptpain, patient's pain assessment; SJ, swollen joint count; TJ, tender joint count.